Moffitt Cancer Center Researcher Receive $100,000 Grant to Study Myeloproliferative Neoplasms

July 11, 2014

TAMPA, Fla. –  Gary W. Reuther, Ph.D., associate member of the Cancer Biology and Evolution Program at Moffitt Cancer Center, received a $100,000 research grant from the MPN Foundation and The Leukemia & Lymphoma Society®. The award is part of the Myeloproliferative Neoplasms (MPN) Challenge, an annual program that distributes $1 million to select researchers who are studying the factors that induce fibrosis in bone marrow, in hopes of stopping or reversing this disease.

Reuther’s research focuses on understanding the significance of the JAK2-V617F mutation in myeloproliferative neoplasms. JAK2 is a tyrosine kinase and the V617F mutation leads to constant kinase activity, which progresses MPN. Reuther and his team are working on JAK2 inhibitors, as well as other alternative strategies to target MPN cells. 

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41
National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.